No level I data are available. Nonetheless, our analysis suggests that laser surgery and radiotherapy produce comparable outcomes. Copyright © 2011 S. Karger AG, Basel Laryngeal carcinoma is one of the most common head and neck cancers. According to the most recent estimate, 151,000 new cases (approximately 2.0 men and 0.3 women in every 100,000 population) of laryngeal carcinoma were diagnosed worldwide in 2008 [1] . In recent years, however, the incidence rate of laryngeal carcinoma has been increasing in China, apparently due to cigarette smoking, alcohol consumption and industrial pollution [2] .
cal cords produce readily noticeable voice changes [3] ; (2) the true vocal cords in the glottis region of the larynx are devoid of lymphatic drainage [4] .
Early glottic cancer has a relatively good prognosis [5, 6] . The most common treatment options are endoscopic laser surgery and radiotherapy. The goal of the treatment for T1-T2N0M0 glottic cancer is to cure the disease while preserving the vocal cords. Both laser surgery and radiotherapy could achieve high cure rates, but which treatment is superior in voice preservation remains controversial [7] [8] [9] [10] . Superior voice quality has been reported after radiotherapy in several studies [9] [10] [11] whereas one study reported superior voice quality after laser treatment [7] .
There are a few reviews on the use of endoscopic laser surgery and radiotherapy in the treatment of early glottic cancer [11, 12] , and none of these reviews comprehensively assessed cure rates, voice function-preserving capacity and treatment costs. The present meta-analysis is based on reports published in the past two decades. Specifically, carbon dioxide endoscopic laser surgery was compared to radiotherapy in patients with T1-T2N0M0 glottic cancer. Parameters included overall survival, voice preservation and cost.
Methods

Search Strategy
The search was limited to reports published in the English and Chinese languages. Databases were searched using a combination of free text and MESH terms. Surgery were manually searched. The time period of the search was from January 1990 to December 2010. The bibliographies listed in the selected articles were cross-examined to identify additional literature. The authors of the original articles were contacted in case of ambiguity with regard to the design and data.
Inclusion Criteria
All reports included in this review met the following criteria: (1) patients with previously untreated early-stage glottic cancer (i.e. T1-T2N0M0, based on the TNM system); (2) the intervention was carbon dioxide endoscopic laser surgery versus radiotherapy (without salvage procedure). The primary outcome measure was local control rate. The secondary outcome measures included voice handicap index (VHI), quality of life and treatment cost.
Quality Assessment of Included Studies
Retrieved articles were assessed by two independent researchers. The methodological quality of the articles was evaluated by using the ABC rating scale as previously described [13] : level A, high-quality randomized controlled trials; level B, well-designed, nonrandomized clinical trials, and level C, consensus or expert opinions.
Data Collection and Analysis
For each study, the following data were collected: first author, publication year, study design, number of patients, tumor stage, patient sex, treatment and outcome. The data were analyzed using Review Manager 5.0 software (Nordic Cochrane Centre, Copenhagen, Denmark). We statistically synthesized dates of eligible studies if appropriate. For dichotomous outcomes, relative risk (RR) and 95% confidence intervals (CIs) were utilized to compare the event rate. For continuous outcomes, data were summarized using weighted mean difference.
Clinical and methodological heterogeneity was assessed using the 2 test and I 2 test. Meta-analyses were performed whenever appropriate. When there was no significant heterogeneity, a fixed-effect model was employed; otherwise, a random-effect model was adopted and the results from each study were individually described without pooling of the data.
Results
Eligible Studies
Of the 25 potentially eligible trials, 14 were excluded [10, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . The reasons for exclusion are shown in table 1 . Eleven studies [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] met all inclusion criteria and were included in the final analysis. None of the 11 studies was completely randomized in design; 1 was prospective [35] and all others were retrospective. A total of 1,135 participants were included: 539 were treated with laser surgery and 596 with radiotherapy. Detailed information is presented in table 2 .
Local Control Rate
Local control rate was reported in 5 studies [31, 32, 34, 35, 37] . Two studies evaluated the 2-year local control rate [31, 32] , 2 evaluated the 3-year local control [34, 35] , and 3 evaluated the 5-year local control [32, 34, 37] . A metaanalysis of the 5 studies failed to show a significant difference in local control rate at any time (2-year: RR = 0.55, 95% CI: 0.28-1.09; 3-year: RR = 0.84, 95% CI: 0.48-1.47; 5-year: RR = 0.90, 95% CI: 0.59-1.39; fig. 1 ).
Voice Handicap Index
The VHI was reported in 6 trials [27] [28] [29] [30] [31] 36] . Significant heterogeneity prevented a meta-analysis. No significant difference in total VHI score was found in 3 studies [28, 29, 31] . Two studies reported significantly lower VHI scores (p ! 0.05) in patients receiving radiotherapy [27, 30] . The remaining study claimed significantly higher VHI scores (p ! 0.05) in patients receiving radiotherapy [36] . Data with regard to emotional and functional changes were also conflicting. Better emotional scores were achieved by patients receiving laser surgery by Goor et al. [31] whereas Nunez Batalla et al. [30] and Dinapoli et al. [27] reported better emotional scores in patients receiving radiotherapy. Sjögren et al. [29] reported no difference. Better functional scores were reported by Nunez Batalla et al. [30] in patients receiving radiotherapy while Dinapoli et al. [27] , Sjögren et al. [29] and Goor et al. [31] found no difference between the two groups.
Quality of Life
The quality of life was assessed in 2 studies [28, 31] . Goor et al. [31] used the COOP/Wonca chart and found no significant difference between patients receiving laser surgery versus radiotherapy. Patients receiving radiotherapy seemed to do be better in physical fitness and social activities but poorer in mental well-being and daily activities. The differences, however, were not statistically significant. Oridate et al. [28] used Voice-Related Quality of Life and also failed to find significant difference between the two treatment modalities.
Treatment Cost
Two studies [31, 33] described the costs. Both revealed significantly lower total cost for laser surgery. None of the 2 studies assessed loss of income during treatment. In this respect, laser surgery is probably more economical as the treatment typically requires ! 2 days hospital stay whereas radiotherapy typically takes 5 or 6 weeks.
Discussion
Strong and Jako [38] began to use carbon dioxide laser to treat malignant lesions of the larynx in 1972. In the following decades, minimal tissue resection has been in- [39, 40] . Such a change of attitude led to an increase in the popularity of laser surgery as the primary management for early glottic cancer [41] . The most commonly used types of treatment for early glottic cancer are radiotherapy and CO 2 laser surgery [42] . The choice seems to vary significantly across countries. Radiotherapy is preferred in northern Europe whereas patients are more likely to be treated with surgery in the United States and southern Europe [18] . A number of original studies comparing the oncologic and functional outcomes, quality of life and costs of laser surgery and/or radiotherapy in the treatment of early-stage carcinoma were excluded from our meta-analysis because they did not meet the inclusion criteria. Our analysis demonstrated a similar cure rate for radiotherapy [7, 10, 33, 43] and laser surgery [7, 10, 33, [44] [45] [46] , at 66-95% and 76-96%, respectively. The results with regard to voice preservation are inconclusive. Five studies [10, 20, 25, 47, 48] reported no significant difference between the two treatments. Four studies reported [24, 34, 49] better voice quality after radiotherapy. Very few studies concluded that voice quality was better after laser surgery. The costs for T1a glottic cancer are substantially greater in patients treated with radiotherapy than in patients treated with laser surgery [7, 33, 41, 50] . In all, both treatments achieve high and comparable cure rates. However, there remains controversy over voice quality, quality of life, risk of complications and cost. Our meta-analysis failed to show a significant difference between CO 2 laser surgery and radiotherapy in the rate of local control at 2, 3 and 5 years ( fig. 1 ). However, there was significant heterogeneity in patient selection (T1a vs. T1-T2, T1 vs. T1a, T1 vs. T1a vs. T1-2). Also, there is no significant difference between CO 2 laser surgery and radiotherapy in quality of life. Total cost of radiotherapy is significantly higher than that of CO 2 laser surgery.
The current study has several limitations. None of the included studies were randomized controlled clinical trials. Only one study was prospective in design; the remaining studies were retrospective and had a relatively small sample size. Moreover, there was significant heterogeneity in tumor stage, dosing and schedule of radiotherapy, duration prior to voice assessment and the follow-up. Expanding the search to languages beyond English and Chinese might have identified more goodquality studies. 
Conclusion
Our analysis reveals a lack of well-designed prospective studies. Our analysis of the limited evidence failed to identify any difference in local control in patients with early glottic cancer receiving laser surgery versus radiotherapy. The effects on voice preservation require further study. Treatment cost is lower with laser surgery. Based on these findings, we believe that laser surgery is a more attractive option for patients with early glottic cancer based on economic considerations.
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